This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Kenneth L. Davis, MD; Thomas B. Horvath, MD; Richard C. Mohs, PhD; Bonnie M. Davis, MD
Department of Psychiatry Bronx Veterans Administration Medical Center 130 W Kingsbridge Rd Bronx, NY 10468

Arch Gen Psychiatry. 1985;42(9):927-928.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—

Schaefer and colleagues have suggested that the differential responses observed following the administration of apomorphine to schizophrenic patients may be a reflection of sampling bias. Specifically, the inclusion of a majority of patients who are otherwise unresponsive to neuroleptics is proposed as the basis for apomorphine's apparent lack of efficacy. Indeed, this possibility deserves consideration, although it is made somewhat less likely by the fact that studies by Ferrier,¹ Meltzer,² Hollister et al,³ and ourselves⁴ have included over 80 patients and not a single patient has been reported to have had a clinically meaningful response to apomorphine.

An alternative explanation for the variable response to apomorphine might center around the dose of apomorphine administered, as well as whether neuroleptics were concomitantly administered. Those trials in which apomorphine alone was given, due to the adverse effects of apomorphine at higher doses, were restricted to relatively low doses . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?